These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 11595210)

  • 1. Long-term neuroprotective effect of inhibiting poly(ADP-ribose) polymerase in rats with middle cerebral artery occlusion using a behavioral assessment.
    Ding Y; Zhou Y; Lai Q; Li J; Gordon V; Diaz FG
    Brain Res; 2001 Oct; 915(2):210-7. PubMed ID: 11595210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroprotective effect of combination of poly (ADP-ribose) polymerase inhibitor and antioxidant in middle cerebral artery occlusion induced focal ischemia in rats.
    Gupta S; Kaul CL; Sharma SS
    Neurol Res; 2004 Jan; 26(1):103-7. PubMed ID: 14977067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Post-treatment with an inhibitor of poly(ADP-ribose) polymerase attenuates cerebral damage in focal ischemia.
    Takahashi K; Pieper AA; Croul SE; Zhang J; Snyder SH; Greenberg JH
    Brain Res; 1999 May; 829(1-2):46-54. PubMed ID: 10350529
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative study of neuroprotective effect of single and combined blockade of AT1 receptor and PARP-1 in focal cerebral ischaemia in rat.
    Singh N; Sharma G; Singh N; Hanif K
    Int J Stroke; 2014 Jul; 9(5):560-8. PubMed ID: 23013350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase.
    Moroni F; Cozzi A; Chiarugi A; Formentini L; Camaioni E; Pellegrini-Giampietro DE; Chen Y; Liang S; Zaleska MM; Gonzales C; Wood A; Pellicciari R
    Br J Pharmacol; 2012 Mar; 165(5):1487-500. PubMed ID: 21913897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.
    Koh SH; Park Y; Song CW; Kim JG; Kim K; Kim J; Kim MH; Lee SR; Kim DW; Yu HJ; Chang DI; Hwang SJ; Kim SH
    Eur J Neurosci; 2004 Sep; 20(6):1461-72. PubMed ID: 15355313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chelating intracellularly accumulated zinc decreased ischemic brain injury through reducing neuronal apoptotic death.
    Zhao Y; Pan R; Li S; Luo Y; Yan F; Yin J; Qi Z; Yan Y; Ji X; Liu KJ
    Stroke; 2014 Apr; 45(4):1139-47. PubMed ID: 24643405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced poly(ADP-ribosyl)ation after focal ischemia in rat brain.
    Tokime T; Nozaki K; Sugino T; Kikuchi H; Hashimoto N; Ueda K
    J Cereb Blood Flow Metab; 1998 Sep; 18(9):991-7. PubMed ID: 9740102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of poly(ADP-ribose) polymerase: reduction of ischemic injury and attenuation of N-methyl-D-aspartate-induced neurotransmitter dysregulation.
    Lo EH; Bosque-Hamilton P; Meng W
    Stroke; 1998 Apr; 29(4):830-6. PubMed ID: 9550519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ischemic brain injury is mediated by the activation of poly(ADP-ribose)polymerase.
    Endres M; Wang ZQ; Namura S; Waeber C; Moskowitz MA
    J Cereb Blood Flow Metab; 1997 Nov; 17(11):1143-51. PubMed ID: 9390645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of poly (ADP-ribose) polymerase inhibitors in transient focal cerebral ischemia of rats.
    Sun AY; Cheng JS
    Zhongguo Yao Li Xue Bao; 1998 Mar; 19(2):104-8. PubMed ID: 10374629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 3-Aminobenzamide reduces brain infarction and neutrophil infiltration after transient focal cerebral ischemia in mice.
    Couturier JY; Ding-Zhou L; Croci N; Plotkine M; Margaill I
    Exp Neurol; 2003 Dec; 184(2):973-80. PubMed ID: 14769390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroprotective effect of 4-amino-1,8-napthalimide, a poly(ADP ribose) polymerase inhibitor in middle cerebral artery occlusion-induced focal cerebral ischemia in rat.
    Kabra DG; Thiyagarajan M; Kaul CL; Sharma SS
    Brain Res Bull; 2004 Feb; 62(5):425-33. PubMed ID: 15168908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired motor activity and motor learning function in rat with middle cerebral artery occlusion.
    Ding Y; Zhou Y; Lai Q; Li J; Park H; Diaz FG
    Behav Brain Res; 2002 Apr; 132(1):29-36. PubMed ID: 11853855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A newly synthesized poly(ADP-ribose) polymerase inhibitor, DR2313 [2-methyl-3,5,7,8-tetrahydrothiopyrano[4,3-d]-pyrimidine-4-one]: pharmacological profiles, neuroprotective effects, and therapeutic time window in cerebral ischemia in rats.
    Nakajima H; Kakui N; Ohkuma K; Ishikawa M; Hasegawa T
    J Pharmacol Exp Ther; 2005 Feb; 312(2):472-81. PubMed ID: 15466246
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model.
    Ikeda Y; Hokamura K; Kawai T; Ishiyama J; Ishikawa K; Anraku T; Uno T; Umemura K
    Brain Res; 2005 Oct; 1060(1-2):73-80. PubMed ID: 16202986
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel and potent poly(ADP-ribose) polymerase-1 inhibitor, FR247304 (5-chloro-2-[3-(4-phenyl-3,6-dihydro-1(2H)-pyridinyl)propyl]-4(3H)-quinazolinone), attenuates neuronal damage in in vitro and in vivo models of cerebral ischemia.
    Iwashita A; Tojo N; Matsuura S; Yamazaki S; Kamijo K; Ishida J; Yamamoto H; Hattori K; Matsuoka N; Mutoh S
    J Pharmacol Exp Ther; 2004 Aug; 310(2):425-36. PubMed ID: 15075382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of PJ34, a novel, potent inhibitor of poly(ADP-ribose) polymerase (PARP) in in vitro and in vivo models of stroke.
    Abdelkarim GE; Gertz K; Harms C; Katchanov J; Dirnagl U; Szabó C; Endres M
    Int J Mol Med; 2001 Mar; 7(3):255-60. PubMed ID: 11179503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinatorial-approached neuroprotection using pan-caspase inhibitor and poly (ADP-ribose) polymerase (PARP) inhibitor following experimental stroke in rats; is there additional benefit?
    Yap E; Tan WL; Ng I; Ng YK
    Brain Res; 2008 Feb; 1195():130-8. PubMed ID: 18207135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poly(ADP-ribose) synthase inhibition reduces ischemic injury and inflammation in neonatal rat brain.
    Ducrocq S; Benjelloun N; Plotkine M; Ben-Ari Y; Charriaut-Marlangue C
    J Neurochem; 2000 Jun; 74(6):2504-11. PubMed ID: 10820212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.